423 related articles for article (PubMed ID: 17129733)
21. Syntheses and anti-cancer activities of 2-[1-(indol-3-yl-/pyrimidin-5-yl-/pyridine-2-yl-/quinolin-2-yl)-but-3-enylamino]-2-phenyl-ethanols.
Singh P; Kaur P; Luxami V; Kaur S; Kumar S
Bioorg Med Chem; 2007 Mar; 15(6):2386-95. PubMed ID: 17275313
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
Chen Z; Cao R; Shi B; Guo L; Sun J; Ma Q; Fan W; Song H
Eur J Med Chem; 2011 Oct; 46(10):5127-37. PubMed ID: 21875764
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of N-heterocyclic indolyl glyoxylamides as orally active anticancer agents.
Li WT; Hwang DR; Chen CP; Shen CW; Huang CL; Chen TW; Lin CH; Chang YL; Chang YY; Lo YK; Tseng HY; Lin CC; Song JS; Chen HC; Chen SJ; Wu SH; Chen CT
J Med Chem; 2003 Apr; 46(9):1706-15. PubMed ID: 12699388
[TBL] [Abstract][Full Text] [Related]
25. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
[TBL] [Abstract][Full Text] [Related]
26. Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition.
Chaniyara R; Tala S; Chen CW; Zang X; Kakadiya R; Lin LF; Chen CH; Chien SI; Chou TC; Tsai TH; Lee TC; Shah A; Su TL
J Med Chem; 2013 Feb; 56(4):1544-63. PubMed ID: 23360284
[TBL] [Abstract][Full Text] [Related]
27. Quinols as novel therapeutic agents. 7.1 Synthesis of antitumor 4-[1-(arylsulfonyl-1H-indol-2-yl)]-4-hydroxycyclohexa-2,5-dien-1-ones by Sonogashira reactions.
McCarroll AJ; Bradshaw TD; Westwell AD; Matthews CS; Stevens MF
J Med Chem; 2007 Apr; 50(7):1707-10. PubMed ID: 17343370
[TBL] [Abstract][Full Text] [Related]
28. Novel heterocyclic family of phenyl naphthothiazole carboxamides derived from naphthalimides: synthesis, antitumor evaluation, and DNA photocleavage.
Li Z; Yang Q; Qian X
Bioorg Med Chem; 2005 May; 13(9):3149-55. PubMed ID: 15809150
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, biological activity, and DNA-damage profile of platinum-threading intercalator conjugates designed to target adenine.
Guddneppanavar R; Saluta G; Kucera GL; Bierbach U
J Med Chem; 2006 Jun; 49(11):3204-14. PubMed ID: 16722638
[TBL] [Abstract][Full Text] [Related]
30. Syntheses and antiproliferative activities of 7-azarebeccamycin analogues bearing one 7-azaindole moiety.
Marminon C; Pierré A; Pfeiffer B; Pérez V; Léonce S; Joubert A; Bailly C; Renard P; Hickman J; Prudhomme M
J Med Chem; 2003 Feb; 46(4):609-22. PubMed ID: 12570382
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
32. Bis-naphthylureas and related compounds: synthesis, chemical properties, DNA affinity and antineoplastic activity.
Bruno AM; Asis SE; Gaozza CH
Pharmazie; 2001 May; 56(5):361-5. PubMed ID: 11400549
[TBL] [Abstract][Full Text] [Related]
33. Dimeric analogues of non-cationic tricyclic aromatic carboxamides are a new class of cytotoxic agents.
Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
Anticancer Drug Des; 1999 Jun; 14(3):281-9. PubMed ID: 10500503
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of 1-methyl-2,3-dimethyl-N(isopropyl)carbamates-4,5-dihydro-7-R'- 8-R-1H-benzo[g]indoles and evaluation of in vitro anticancer activity.
Pinna GA; Pirisi MA; Paglietti G
Farmaco; 1994 Feb; 49(2):121-6. PubMed ID: 8003180
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the first cytostatically active 1-aza-9-oxafluorenes as novel selective CDK1 inhibitors with P-glycoprotein modulating properties.
Brachwitz K; Voigt B; Meijer L; Lozach O; Schächtele C; Molnár J; Hilgeroth A
J Med Chem; 2003 Feb; 46(5):876-9. PubMed ID: 12593668
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
Virsodia V; Manvar A; Upadhyay K; Loriya R; Karia D; Jaggi M; Singh A; Mukherjee R; Shaikh MS; Coutinho EC; Shah A
Eur J Med Chem; 2009 Mar; 44(3):1355-62. PubMed ID: 18316139
[TBL] [Abstract][Full Text] [Related]
37. Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activity.
Diana P; Martorana A; Barraja P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
Bioorg Med Chem; 2007 Jan; 15(1):343-9. PubMed ID: 17064918
[TBL] [Abstract][Full Text] [Related]
38. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity.
Gatto B; Zagotto G; Sissi C; Cera C; Uriarte E; Palù G; Capranico G; Palumbo M
J Med Chem; 1996 Aug; 39(16):3114-22. PubMed ID: 8759632
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and cytotoxicity of 2-methyl-4, 9-dihydro-1-substituted-1H-imidazo[4,5-g]quinoxaline-4,9-diones and 2,3-disubstituted-5,10-pyrazino[2,3-g]quinoxalinediones.
Yoo HW; Suh ME; Park SW
J Med Chem; 1998 Nov; 41(24):4716-22. PubMed ID: 9822542
[TBL] [Abstract][Full Text] [Related]
40. Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.
Ohara K; Smietana M; Restouin A; Mollard S; Borg JP; Collette Y; Vasseur JJ
J Med Chem; 2007 Dec; 50(26):6465-75. PubMed ID: 18052116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
